Pharmacologic control of CAR-T cell function using dasatinib

被引：174

作者：

Weber, Evan W. ^{[1
]}

Lynn, Rachel C. ^{[1
]}

Sotillo, Elena ^{[1
]}

Lattin, John ^{[1
]}

Xu, Peng ^{[1
]}

Mackall, Crystal L. ^{[1
,2
,3
]}

机构：

[1] Stanford Univ, Sch Med, Stanford Canc Inst, Stanford, CA 94305 USA

[2] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA

[3] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA

来源：

BLOOD ADVANCES | 2019年 / 3卷 / 05期

基金：

美国国家卫生研究院;

关键词：

BLOOD-BRAIN-BARRIER; KINASE INHIBITOR; SUICIDE GENE; B-CELL; TOXICITIES; THERAPY; LYMPHOCYTES; ACTIVATION; MANAGEMENT; SYSTEM;

D O I：

10.1182/bloodadvances.2018028720

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：711 / 717

页数：7

共 27 条

[1] Noninvasive bioluminescent imaging of primary patient acute lymphoblastic leukemia: a strategy for preclinical modeling [J].

Barrett, David M. ;

Seif, Alix E. ;

Carpenito, Carmine ;

Teachey, David T. ;

Fish, Jonathan D. ;

June, Carl H. ;

Grupp, Stephan A. ;

Reid, Gregor S. D. .

BLOOD, 2011, 118 (15) :E112-E117

[2] The Src/ABL kinase inhibitor dasatinib (BMS-354825) inhibits function of normal human T-lymphocytes in vitro [J].

Blake, Stephen ;

Hughes, Timothy P. ;

Mayrhofer, Graham ;

Lyons, A. Bruce .

CLINICAL IMMUNOLOGY, 2008, 127 (03) :330-339

[3] Toxicities of chimeric antigen receptor T cells: recognition and management [J].

Brudno, Jennifer N. ;

Kochenderfer, James N. .

BLOOD, 2016, 127 (26) :3321-3330

[4] Chimeric antigen receptor T cells form nonclassical and potent immune synapses driving rapid cytotoxicity [J].

Davenport, A. J. ;

Cross, R. S. ;

Watson, K. A. ;

Liao, Y. ;

Shi, W. ;

Prince, H. M. ;

Beavis, P. A. ;

Trapani, J. A. ;

Kershaw, M. H. ;

Ritchie, D. S. ;

Darcy, P. K. ;

Neeson, P. J. ;

Jenkins, M. R. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2018, 115 (09) :E2068-E2076

[5] Phase I Dose-Escalation and Pharmacokinetic Study of Dasatinib in Patients with Advanced Solid Tumors [J].

Demetri, George D. ;

Lo Russo, Patricia ;

MacPherson, Lain R. J. ;

Wang, Ding ;

Morgan, Jeffrey A. ;

Brunton, Valerie G. ;

Paliwal, Prashni ;

Agrawal, Shruti ;

Voi, Maurizio ;

Evan, T. R. Jeffry .

CLINICAL CANCER RESEARCH, 2009, 15 (19) :6232-6240

[6] Inducible Caspase-9 Selectively Modulates the Toxicities of CD19-Specific Chimeric Antigen Receptor-Modified T Cells [J].

Diaconu, Iulia ;

Ballard, Brandon ;

Zhang, Ming ;

Chen, Yuhui ;

West, John ;

Dotti, Gianpietro ;

Savoldols, Barbara .

MOLECULAR THERAPY, 2017, 25 (03) :580-592

[7] The inducible caspase-9 suicide gene system as a "safety switch" to limit on-target, off-tumor toxicities of chimeric antigen receptor T cells [J].

Gargett, Tessa ;

Brown, Michael P. .

FRONTIERS IN PHARMACOLOGY, 2014, 5

[8] CAR T cell-induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade [J].

Giavridis, Theodoros ;

van der Stegen, Sjoukje J. C. ;

Eyquem, Justin ;

Hamieh, Mohamad ;

Piersigilli, Alessandra ;

Sadelain, Michel .

NATURE MEDICINE, 2018, 24 (06) :731-+

[9] Endothelial Activation and Blood-Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells [J].

Gust, Juliane ;

Hay, Kevin A. ;

Hanafi, Laila-Aicha ;

Li, Daniel ;

Myerson, David ;

Gonzalez-Cuyar, Luis F. ;

Yeung, Cecilia ;

Liles, W. Conrad ;

Wurfel, Mark ;

Lopez, Jose A. ;

Chen, Junmei ;

Chung, Dominic ;

Harju-Baker, Susanna ;

Tzpolat, Tahsin ;

Fink, Kathleen R. ;

Riddell, Stanley R. ;

Maloney, David G. ;

Turtle, Cameron J. .

CANCER DISCOVERY, 2017, 7 (12) :1404-1419

[10] Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma/leukemia effects and safety [J].

Hoyos, V. ;

Savoldo, B. ;

Quintarelli, C. ;

Mahendravada, A. ;

Zhang, M. ;

Vera, J. ;

Heslop, H. E. ;

Rooney, C. M. ;

Brenner, M. K. ;

Dotti, G. .

LEUKEMIA, 2010, 24 (06) :1160-1170

← 1 2 3 →